Ad is loading...
CAFCX
Price
$36.09
Change
-$0.73 (-1.98%)
Updated
Nov 15 closing price
RGAGX
Price
$80.17
Change
-$1.35 (-1.66%)
Updated
Nov 15 closing price
Ad is loading...

CAFCX vs RGAGX

Header iconCAFCX vs RGAGX Comparison
Open Charts CAFCX vs RGAGXBanner chart's image
American Funds AMCAP 529C
Price$36.09
Change-$0.73 (-1.98%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R6
Price$80.17
Change-$1.35 (-1.66%)
VolumeN/A
CapitalizationN/A
CAFCX vs RGAGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CAFCX vs. RGAGX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAFCX is a Sell and RGAGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGAGX has more cash in the bank: 298B vs. CAFCX (89.3B). RGAGX pays higher dividends than CAFCX: RGAGX (0.75) vs CAFCX (0.00). CAFCX was incepted earlier than RGAGX: CAFCX (23 years) vs RGAGX (16 years). CAFCX (31.00) and RGAGX (31.00) have comparable annual turnover. CAFCX (250) and RGAGX (250) have matching initial minimum investment requirements. RGAGX annual gain was more profitable for investors over the last year : 28.44 vs. CAFCX (21.23). RGAGX return over 5 years is better than : 54.50 vs. CAFCX (24.28).
CAFCXRGAGXCAFCX / RGAGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years16 years-
Gain YTD15.97026.83160%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets89.3B298B30%
Annual Yield % from dividends0.000.75-
Returns for 1 year21.2328.4475%
Returns for 3 years-11.11-3.76295%
Returns for 5 years24.2854.5045%
Returns for 10 years30.5772.6542%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UAA9.940.09
+0.91%
Under Armour
EXPD120.16-0.80
-0.66%
Expeditors International of Washington
SSKN3.01-0.09
-2.90%
Strata Skin Sciences
MD14.15-0.61
-4.13%
Pediatrix Medical Group
CMPX1.38-0.21
-13.21%
Compass Therapeutics